Ready to play
Ready to play
The National Cancer Control Authority announced the arrival of a new shipment of cancer treatment medications sourced from Baxter Corporation. The shipment includes items such as Liposomal Doxorubicin 20 mg, Mesna 400 mg, Endoxan 1 g, and Holoxan 1 g, as well as other preparations in various dosages. The shipment is currently undergoing regulatory clearance procedures, in preparation for its direct distribution to cancer treatment centers and units once all necessary procedures are completed. This step is part of the authority's efforts to ensure the availability of specialized cancer medications and to facilitate swift and effective access to them.
Notice: This Is an AI-Generated Summary
Comments (0)